CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Operating Income
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Operating Income of $119.89 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for the quarter ending 2026-06-27 was $119.89M, a 19.73% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for the quarter ending 2026-03-28 was $119.90M, a 60.57% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for the quarter ending 2025-12-27 was -$283.44M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for the quarter ending 2025-09-27 was $133.80M, a 13.96% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for fiscal 2025 was $25.16M, a 88.93% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for fiscal 2024 was $227.35M, a 63.17% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for fiscal 2023 was $617.26M, a 5.18% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating income (loss) for fiscal 2022 was $650.98M, a 10.36% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $119.89M 10-Q · filed 2026-08-05 | $239.78M 10-Q · filed 2026-08-05 | -$43.66M derived: sum of 3 quarters · filed 2026-08-05 | $90.14M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $119.90M 10-Q · filed 2026-05-07 | -$163.54M derived: sum of 2 quarters · filed 2026-05-07 | -$29.74M derived: sum of 3 quarters · filed 2026-05-07 | $70.39M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-27 | -$283.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$149.64M derived: sum of 2 quarters · filed 2026-02-18 | -$49.51M derived: sum of 3 quarters · filed 2026-08-05 | $25.16M 10-K · filed 2026-02-18 | ||||
| 2025-09-27 | $133.80M 10-Q · filed 2025-11-05 | $233.93M derived: sum of 2 quarters · filed 2026-08-05 | $308.60M 10-Q · filed 2025-11-05 | $140.91M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $100.13M 10-Q · filed 2026-08-05 | $174.80M 10-Q · filed 2026-08-05 | $7.12M derived: sum of 3 quarters · filed 2026-08-05 | $124.52M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | $74.67M 10-Q · filed 2026-05-07 | -$93.02M derived: sum of 2 quarters · filed 2026-05-07 | $24.39M derived: sum of 3 quarters · filed 2026-05-07 | $176.04M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-28 | -$167.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$50.28M derived: sum of 2 quarters · filed 2026-02-18 | $101.37M derived: sum of 3 quarters · filed 2026-02-18 | $227.35M 10-K · filed 2026-02-18 | ||||
| 2024-09-28 | $117.41M 10-Q · filed 2025-11-05 | $269.06M derived: sum of 2 quarters · filed 2025-11-05 | $395.03M 10-Q · filed 2025-11-05 | $527.96M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-06-29 | $151.65M 10-Q · filed 2025-08-06 | $277.63M 10-Q · filed 2025-08-06 | $410.55M derived: sum of 3 quarters · filed 2026-02-18 | $562.05M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-03-30 | $125.98M 10-Q · filed 2025-05-07 | $258.90M derived: sum of 2 quarters · filed 2026-02-18 | $410.40M derived: sum of 3 quarters · filed 2026-02-18 | $575.35M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-30 | $132.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $284.42M derived: sum of 2 quarters · filed 2026-02-18 | $449.37M derived: sum of 3 quarters · filed 2026-02-18 | $617.26M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | $151.50M 10-Q · filed 2024-11-06 | $316.45M derived: sum of 2 quarters · filed 2024-11-06 | $484.34M 10-Q · filed 2024-11-06 | $648.15M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-07-01 | $164.94M 10-Q · filed 2024-08-07 | $332.84M 10-Q · filed 2024-08-07 | $496.65M derived: sum of 3 quarters · filed 2025-02-19 | $647.62M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-04-01 | $167.89M 10-Q · filed 2024-05-09 | $331.70M derived: sum of 2 quarters · filed 2025-02-19 | $482.68M derived: sum of 3 quarters · filed 2025-02-19 | $670.09M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $163.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $314.79M derived: sum of 2 quarters · filed 2025-02-19 | $502.20M derived: sum of 3 quarters · filed 2025-02-19 | $650.98M 10-K · filed 2025-02-19 | ||||
| 2022-09-24 | $150.98M 10-Q · filed 2023-11-08 | $338.39M derived: sum of 2 quarters · filed 2023-11-08 | $487.17M 10-Q · filed 2023-11-08 | $659.97M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-25 | $187.41M 10-Q · filed 2023-08-09 | $336.19M 10-Q · filed 2023-08-09 | $509.00M derived: sum of 3 quarters · filed 2024-02-14 | $664.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-26 | $148.78M 10-Q · filed 2023-05-11 | $321.58M derived: sum of 2 quarters · filed 2024-02-14 | $477.39M derived: sum of 3 quarters · filed 2024-02-14 | $614.94M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-25 | $172.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $328.61M derived: sum of 2 quarters · filed 2024-02-14 | $466.16M derived: sum of 3 quarters · filed 2024-02-14 | $589.86M 10-K · filed 2024-02-14 | ||||
| 2021-09-25 | $155.80M 10-Q · filed 2022-11-02 | $293.35M derived: sum of 2 quarters · filed 2022-11-02 | $417.06M 10-Q · filed 2022-11-02 | $545.98M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-26 | $137.55M 10-Q · filed 2022-08-03 | $261.25M 10-Q · filed 2022-08-03 | $390.18M derived: sum of 3 quarters · filed 2022-08-03 | $522.93M derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-27 | $123.70M 10-Q · filed 2022-05-04 | $252.63M derived: sum of 2 quarters · filed 2022-05-04 | $385.38M derived: sum of 3 quarters · filed 2022-05-04 | $462.15M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-26 | $128.93M 10-K · filed 2021-02-17 | $261.68M derived: sum of 2 quarters · filed 2021-11-03 | $338.45M derived: sum of 3 quarters · filed 2021-11-03 | $432.73M 10-K · filed 2023-02-22 | ||||
| 2020-09-26 | $132.75M 10-Q · filed 2021-11-03 | $209.52M derived: sum of 2 quarters · filed 2021-11-03 | $303.80M 10-Q · filed 2021-11-03 | $412.59M derived: sum of 4 quarters · filed 2021-11-03 | ||||
| 2020-06-27 | $76.77M 10-Q · filed 2021-08-04 | $171.05M 10-Q · filed 2021-08-04 | $279.84M derived: sum of 3 quarters · filed 2021-08-04 | $372.64M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-28 | $94.28M 10-Q · filed 2021-05-04 | $203.07M derived: sum of 2 quarters · filed 2021-05-04 | $295.87M derived: sum of 3 quarters · filed 2021-05-04 | $375.64M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-12-28 | $108.79M 10-K · filed 2021-02-17 | $201.59M derived: sum of 2 quarters · filed 2021-02-17 | $281.36M derived: sum of 3 quarters · filed 2021-02-17 | $351.15M 10-K · filed 2022-02-16 | ||||
| 2019-09-28 | $92.80M 10-K · filed 2021-02-17 | $172.57M derived: sum of 2 quarters · filed 2021-02-17 | $242.36M 10-Q · filed 2020-10-29 | $344.84M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-29 | $79.77M 10-K · filed 2021-02-17 | $149.56M 10-Q · filed 2020-08-05 | $252.04M derived: sum of 3 quarters · filed 2021-02-17 | $336.40M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-30 | $69.79M 10-K · filed 2021-02-17 | $172.27M derived: sum of 2 quarters · filed 2021-02-17 | $256.64M derived: sum of 3 quarters · filed 2021-02-17 | $333.35M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-29 | $102.48M 10-K · filed 2020-02-11 | $186.84M derived: sum of 2 quarters · filed 2020-02-11 | $263.55M derived: sum of 3 quarters · filed 2020-02-11 | $331.38M 10-K · filed 2021-02-17 | ||||
| 2018-09-29 | $84.36M 10-K · filed 2020-02-11 | $161.07M derived: sum of 2 quarters · filed 2020-02-11 | $228.90M 10-Q · filed 2019-11-06 | $291.73M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-06-30 | $76.71M 10-K · filed 2020-02-11 | $144.54M 10-Q · filed 2019-07-31 | $207.37M derived: sum of 3 quarters · filed 2020-02-11 | $281.43M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-03-31 | $67.83M 10-K · filed 2020-02-11 | $130.66M derived: sum of 2 quarters · filed 2020-02-11 | $204.72M derived: sum of 3 quarters · filed 2020-02-11 | $286.40M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2017-12-30 | $62.83M 10-K · filed 2019-02-13 | $62.73M 10-K · filed 2018-02-13 | $136.89M derived: sum of 2 quarters · filed 2019-02-13 | $218.57M derived: sum of 3 quarters · filed 2019-02-13 | $288.28M 10-K · filed 2020-02-11 | $287.50M 10-K · filed 2018-02-13 | ||
| 2017-09-30 | $74.06M 10-K · filed 2019-02-13 | $73.98M 10-Q · filed 2017-11-09 | $155.75M derived: sum of 2 quarters · filed 2019-02-13 | $225.45M 10-Q · filed 2018-11-07 | $224.77M 10-Q · filed 2017-11-09 | $294.55M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-07-01 | $81.69M 10-K · filed 2019-02-13 | $81.31M 10-Q · filed 2017-08-09 | $151.39M 10-Q · filed 2018-08-08 | $150.78M 10-Q · filed 2017-08-09 | $220.48M derived: sum of 3 quarters · filed 2019-02-13 | $279.28M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-04-01 | $69.71M 10-K · filed 2019-02-13 | $69.47M 10-Q · filed 2017-05-10 | $138.80M derived: sum of 2 quarters · filed 2019-02-13 | $197.59M derived: sum of 3 quarters · filed 2019-02-13 | $255.65M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | $69.09M 10-K · filed 2018-02-13 | $127.89M derived: sum of 2 quarters · filed 2018-02-13 | $185.95M derived: sum of 3 quarters · filed 2018-02-13 | $237.55M 10-K · filed 2019-02-13 | $237.42M 10-K · filed 2017-02-14 | |||
| 2016-09-24 | $58.80M 10-K · filed 2018-02-13 | $116.86M derived: sum of 2 quarters · filed 2018-02-13 | $168.33M 10-Q · filed 2017-11-09 | $220.60M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-25 | $58.06M 10-K · filed 2018-02-13 | $109.53M 10-Q · filed 2017-08-09 | $161.80M derived: sum of 3 quarters · filed 2018-02-13 | $217.24M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-26 | $51.47M 10-K · filed 2018-02-13 | $103.74M derived: sum of 2 quarters · filed 2018-02-13 | $159.18M derived: sum of 3 quarters · filed 2018-02-13 | $214.92M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2015-12-26 | $52.27M 10-K · filed 2017-02-14 | $107.71M derived: sum of 2 quarters · filed 2017-02-14 | $163.44M derived: sum of 3 quarters · filed 2017-02-14 | $206.45M 10-K · filed 2018-02-13 | ||||
| 2015-09-26 | $55.44M 10-K · filed 2017-02-14 | $111.17M derived: sum of 2 quarters · filed 2017-02-14 | $154.18M 10-Q · filed 2016-11-02 | $194.95M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-27 | $55.73M 10-K · filed 2017-02-14 | $98.74M 10-Q · filed 2016-08-03 | $139.51M derived: sum of 3 quarters · filed 2017-02-14 | $185.68M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-28 | $43.01M 10-K · filed 2017-02-14 | $83.77M derived: sum of 2 quarters · filed 2017-02-14 | $129.94M derived: sum of 3 quarters · filed 2017-02-14 | $180.97M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-27 | $40.77M 10-K · filed 2016-02-12 | $86.94M derived: sum of 2 quarters · filed 2016-02-12 | $137.96M derived: sum of 3 quarters · filed 2016-02-12 | $177.67M 10-K · filed 2017-02-14 | ||||
| 2014-09-27 | $46.17M 10-K · filed 2016-02-12 | $97.20M derived: sum of 2 quarters · filed 2016-02-12 | $136.90M 10-Q · filed 2015-11-04 | $161.51M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-28 | $51.02M 10-K · filed 2016-02-12 | $90.73M 10-Q · filed 2015-07-30 | $115.34M derived: sum of 3 quarters · filed 2016-02-12 | $156.18M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-29 | $39.71M 10-K · filed 2016-02-12 | $64.31M derived: sum of 2 quarters · filed 2016-02-12 | $105.16M derived: sum of 3 quarters · filed 2016-02-12 | $148.34M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-28 | $24.61M 10-K · filed 2015-02-17 | $65.45M derived: sum of 2 quarters · filed 2015-02-17 | $108.64M derived: sum of 3 quarters · filed 2015-02-17 | $151.40M 10-K · filed 2016-02-12 | ||||
| 2013-09-28 | $40.84M 10-K · filed 2015-02-17 | $84.03M derived: sum of 2 quarters · filed 2015-02-17 | $126.79M 10-Q · filed 2014-10-30 | $161.86M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-29 | $43.19M 10-K · filed 2015-02-17 | $85.95M 10-Q · filed 2014-08-07 | $121.02M derived: sum of 3 quarters · filed 2015-02-17 | $158.70M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-30 | $42.76M 10-K · filed 2015-02-17 | $77.83M derived: sum of 2 quarters · filed 2015-02-17 | $115.51M derived: sum of 3 quarters · filed 2015-02-17 | $164.79M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-29 | $35.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $72.75M derived: sum of 2 quarters · filed 2015-02-17 | $122.03M derived: sum of 3 quarters · filed 2015-02-17 | $165.76M 10-K · filed 2015-02-17 | ||||
| 2012-09-29 | $37.68M 10-Q · filed 2013-10-30 | $86.96M derived: sum of 2 quarters · filed 2013-10-30 | $130.70M 10-Q · filed 2013-10-30 | $172.34M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $49.27M 10-Q · filed 2013-07-31 | $93.01M 10-Q · filed 2013-07-31 | $134.66M derived: sum of 3 quarters · filed 2014-02-25 | $171.75M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $43.74M 10-Q · filed 2013-05-08 | $85.39M derived: sum of 2 quarters · filed 2014-02-25 | $122.48M derived: sum of 3 quarters · filed 2014-02-25 | $175.79M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $41.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $78.74M derived: sum of 2 quarters · filed 2014-02-25 | $132.06M derived: sum of 3 quarters · filed 2014-02-25 | $174.31M 10-K · filed 2014-02-25 | ||||
| 2011-09-24 | $37.09M 10-Q · filed 2012-11-01 | $90.41M derived: sum of 2 quarters · filed 2012-11-01 | $132.66M 10-Q · filed 2012-11-01 | -$232.50M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-25 | $53.31M 10-Q · filed 2012-08-07 | $95.56M 10-Q · filed 2012-08-07 | -$269.59M derived: sum of 3 quarters · filed 2013-02-27 | -$263.13M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-26 | $42.25M 10-Q · filed 2012-05-04 | -$322.91M derived: sum of 2 quarters · filed 2013-02-27 | -$316.44M derived: sum of 3 quarters · filed 2013-02-27 | -$286.45M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-25 | -$365.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$358.69M derived: sum of 2 quarters · filed 2013-02-27 | -$328.71M derived: sum of 3 quarters · filed 2013-02-27 | -$298.51M 10-K · filed 2013-02-27 | ||||
| 2010-09-25 | $6.47M 10-Q · filed 2011-11-02 | $5.11M 10-Q · filed 2010-11-04 | $36.45M derived: sum of 2 quarters · filed 2011-11-02 | $66.65M 10-Q · filed 2011-11-02 | $62.82M 10-Q · filed 2010-11-04 | $101.26M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-26 | $29.98M 10-Q · filed 2011-08-03 | $28.20M 10-Q · filed 2010-08-03 | $60.18M 10-Q · filed 2011-08-03 | $57.71M 10-Q · filed 2010-08-03 | $94.79M derived: sum of 3 quarters · filed 2012-02-27 | $139.24M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-27 | $30.19M 10-Q · filed 2011-05-04 | $64.81M derived: sum of 2 quarters · filed 2012-02-27 | $109.25M derived: sum of 3 quarters · filed 2012-02-27 | $159.91M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-26 | $34.61M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $79.06M derived: sum of 2 quarters · filed 2012-02-27 | $129.72M derived: sum of 3 quarters · filed 2012-02-27 | $169.61M 10-K · filed 2012-02-27 | ||||
| 2009-09-26 | $44.45M 10-Q · filed 2010-11-04 | $95.11M derived: sum of 2 quarters · filed 2010-11-04 | $135.00M 10-Q · filed 2010-11-04 | |||||
| 2009-06-27 | $50.66M 10-Q · filed 2010-08-03 | $90.56M 10-Q · filed 2010-08-03 | ||||||
| 2008-12-27 | -$451.84M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |